Abstract
Mr. A, a 68-year-old male with no history of renal disease, was evaluated for upper respiratory symptoms including cough and postnasal drip. A 10-day course of amoxicillin was prescribed for presumed sinusitis. After 2 weeks, his symptoms did not improve, and levofloxacin was started. One month after the initial presentation, he presented to the emergency department with progressive dyspnea, abdominal pain, and nausea. Serum creatinine level is 7.1 mg/dL (1 month ago, serum creatinine was 1.0 mg/dL), and he is admitted to the hospital for urgent evaluation. On exam, he is afebrile, and blood pressure is 162/90 mmHg. Scattered bilateral pulmonary crackles were noted on exam, and chest X-ray revealed bilateral nodular pulmonary infiltrates. Urinalysis showed 3+ protein with renal epithelial cells, granular casts, 50 red blood cells (RBCs) per high power field (HPF) with many dysmorphic RBCs, and RBC casts on microscopy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10):1628–36.
Couser W. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis. 1988;11(6):449–64.
Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337(21):1512–23.
Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63(3):1164–77.
Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997;8(2):314–22.
Chen M, Kallenberg CGM, Zhao M-H. ANCA-negative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol. 2009;5(6):313–8.
Koyama A, Yamagata K, Makino H, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009;13(6):633–50.
Lin W, Chen M, Cui Z, Zhao MH. The immunopathological spectrum of crescentic glomerulonephritis: a survey of 106 patients in a single Chinese center. Nephron Clin Pract. 2010;116(1):c65–74.
Denton M, Magee C, Niles J. Rapidly progressive glomerulonephritis. Ann Intern Med. 2002;137(5 Part 1):W1.
Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 2004;66(4):1535–40.
Rutgers A, Slot M, van Paassen P, van Breda VP, Heeringa P, Tervaert JWC. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis. 2005;46(2):253–62.
Papiris S, Manali E, Kalomenidis I, Kapotsis G, Karakatsani A, Roussos C. Bench-to-bedside review: pulmonary-renal syndromes—an update for the intensivist. Crit Care. 2007;11(3):213.
Wiik A. Drug-induced vasculitis. Curr Opin Rheumatol. 2008;20(1):35–9.
Bomback AS, Appel GB. Updates on the treatment of lupus nephritis. J Am Soc Nephrol. 2010;21(12):2028–35.
Falk RJ, Jennette JC. ANCA disease: where is this field heading? J Am Soc Nephrol. 2010;21(5):745–52.
Jayne DRW, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18(7):2180–8.
Hiemstra TF, Walsh M, Mahr A, et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody–associated vasculitis. J Am Med Assoc. 2010;304(21):2381–8.
Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349(1):36–44.
Pagnoux C, Mahr A, Hamidou MA, et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med. 2008;359(26):2790–803.
Jones RB, Cohen Tervaert JW, Hauser T, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010;363(3):211–20.
Melander C, Sallée M, Trolliet P, et al. Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome. Clin J Am Soc Nephrol. 2009;4(3):579–87.
Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221–32.
Falk RJ, Gross WL, Guillevin L, et al. Granulomatosis with polyangiitis (Wegener’s): an alternative name for Wegener’s granulomatosis. J Am Soc Nephrol. 2011;22(4):587–8.
Jayne D. Current management of lupus nephritis: popular misconceptions. Lupus. 2007;16(3):217–20.
Lionaki S, Jennette J, Falk R. Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol. 2007;29(4):459–74.
Ortega LM, Schultz DR, Lenz O, Pardo V, Contreras GN. Review: lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus. 2010;19(5):557–74.
Pallan L, Savage CO, Harper L. ANCA-associated vasculitis: from bench research to novel treatments. Nat Rev Nephrol. 2009;5(5):278–86.
Choy BY, Chan TM, Lai KN. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant. 2006;6(11):2535–42.
Fairhead T, Knoll G. Recurrent glomerular disease after kidney transplantation. Curr Opin Nephrol Hypertens. 2010;19(6):578–85.
Hoffman GS. Therapeutic interventions for systemic vasculitis. J Am Med Assoc. 2010;304(21):2413–4.
Mukhtyar C, Flossmann O, Hellmich B, et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis. 2008;67(7):1004–10.
Hogan SL, Falk RJ, Chin H, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med. 2005;143(9):621–31.
Yu F, Tan Y, Liu G, S-x W, W-z Z, M-h Z. Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int. 2009;76(3):307–17.
Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134(11):1033–42.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
El-Zoghby, Z.M. (2013). Approach to the Patient with Rapidly Progressive Glomerulonephritis. In: Lerma, E., Rosner, M. (eds) Clinical Decisions in Nephrology, Hypertension and Kidney Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4454-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4454-1_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4453-4
Online ISBN: 978-1-4614-4454-1
eBook Packages: MedicineMedicine (R0)